{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:23:09Z","timestamp":1775060589125,"version":"3.50.1"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006752","name":"Universidade do Porto","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006752","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bone cancer pain (BCP) profoundly impacts patient\u2019s quality of life, demanding more effective pain management strategies. The aim of this systematic review was to investigate the role of inflammatory cytokines as potential molecular targets in BCP. A systematic search for animal rodent models of bone cancer pain studies was conducted in PubMed, Scopus, and Web of Science. Methodological quality and risk of bias were assessed using the SYRCLE RoB tool. Twenty-five articles met the inclusion criteria, comprising animal studies investigating molecular targets related to inflammatory cytokines in BCP. A low to moderate risk of bias was reported. Key findings in 23 manuscripts revealed upregulated classic pro-inflammatory cytokines (TNF-\u03b1, IL-1\u03b2, IL-6, IL-17, IL-18, IL-33) and chemokines in the spinal cord, periaqueductal gray, and dorsal root ganglia. Interventions targeting these cytokines consistently mitigated pain behaviors. Additionally, it was demonstrated that glial cells, due to their involvement in the release of inflammatory cytokines, emerged as significant contributors to BCP. This systematic review underscores the significance of inflammatory cytokines as potential molecular targets for alleviating BCP. It emphasizes the promise of targeted interventions and advocates for further research to translate these findings into effective therapeutic strategies. Ultimately, this approach holds the potential to enhance the patient\u2019s quality of life.<\/jats:p>","DOI":"10.1007\/s00109-024-02464-2","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T09:02:31Z","timestamp":1719565351000},"page":"1063-1088","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Molecular targets in bone cancer pain: a systematic review of inflammatory cytokines"],"prefix":"10.1007","volume":"102","author":[{"given":"Jacinta","family":"Ruivo","sequence":"first","affiliation":[]},{"given":"Isaura","family":"Tavares","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2119-4479","authenticated-orcid":false,"given":"Daniel H.","family":"Pozza","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,6,28]]},"reference":[{"key":"2464_CR1","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/s0305-7372(98)90005-6","volume":"24","author":"S Mercadante","year":"1998","unstructured":"Mercadante S, Arcuri E (1998) Breakthrough pain in cancer patients: pathophysiology and treatment. Cancer Treat Rev 24:425\u2013432. https:\/\/doi.org\/10.1016\/s0305-7372(98)90005-6","journal-title":"Cancer Treat Rev"},{"key":"2464_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/s0304-3959(99)00006-8","volume":"81","author":"RK Portenoy","year":"1999","unstructured":"Portenoy RK, Payne D, Jacobsen P (1999) Breakthrough pain: characteristics and impact in patients with cancer pain. Pain 81:129\u2013134. https:\/\/doi.org\/10.1016\/s0304-3959(99)00006-8","journal-title":"Pain"},{"issue":"Pt A","key":"2464_CR3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neulet.2013.08.003","volume":"557","author":"AN Lozano-Ondoua","year":"2013","unstructured":"Lozano-Ondoua AN, Symons-Liguori AM, Vanderah TW (2013) Cancer-induced bone pain: mechanisms and models. Neurosci Lett 557(Pt A):52\u201359. https:\/\/doi.org\/10.1016\/j.neulet.2013.08.003","journal-title":"Neurosci Lett"},{"key":"2464_CR4","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.2147\/JPR.S371337","volume":"15","author":"A Colosia","year":"2022","unstructured":"Colosia A, Njue A, Bajwa Z, Dragon E, Robinson RL, Sheffield KM, Thakkar S, Richiemer SH (2022) The burden of metastatic cancer-induced bone pain: a narrative review. J Pain Res 15:3399\u20133412. https:\/\/doi.org\/10.2147\/JPR.S371337","journal-title":"J Pain Res"},{"key":"2464_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/MJT.0b013e3182456dff","volume":"21","author":"HS Smith","year":"2014","unstructured":"Smith HS, Barkin RL (2014) Painful boney metastases. Am J Ther 21:106\u2013130. https:\/\/doi.org\/10.1097\/MJT.0b013e3182456dff","journal-title":"Am J Ther"},{"key":"2464_CR6","volume-title":"WHO Analgesic LadderStatPearls","author":"AA Anekar","year":"2024","unstructured":"Anekar AA, Hendrix JM, Cascella M (2024) WHO Analgesic LadderStatPearls. Treasure Island (FL)"},{"key":"2464_CR7","doi-asserted-by":"publisher","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","volume":"29","author":"M Fallon","year":"2018","unstructured":"Fallon M, Giusti R, Aielli F, Hoskin P, Rolke R, Sharma M, Ripamonti CI, Committee EG (2018) Management of cancer pain in adult patients: ESMO clinical practice guidelines. Ann Oncol 29:iv166\u2013iv191. https:\/\/doi.org\/10.1093\/annonc\/mdy152","journal-title":"Ann Oncol"},{"key":"2464_CR8","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.hoc.2010.03.002","volume":"24","author":"PL Desandre","year":"2010","unstructured":"Desandre PL, Quest TE (2010) Management of cancer-related pain. Hematol Oncol Clin North Am 24:643\u2013658. https:\/\/doi.org\/10.1016\/j.hoc.2010.03.002","journal-title":"Hematol Oncol Clin North Am"},{"key":"2464_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1156618","author":"D Jing","year":"2023","unstructured":"Jing D, Zhao Q, Zhao Y, Lu X, Feng Y, Zhao B, Zhao X (2023) Management of pain in patients with bone metastases. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2023.1156618","journal-title":"Front Oncol"},{"key":"2464_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neulet.2013.08.003","volume":"557","author":"AN Lozano-Ondoua","year":"2013","unstructured":"Lozano-Ondoua AN, Symons-Liguori AM, Vanderah TW (2013) Cancer-induced bone pain: mechanisms and models. Neurosci Lett 557:52\u201359. https:\/\/doi.org\/10.1016\/j.neulet.2013.08.003","journal-title":"Neurosci Lett"},{"key":"2464_CR11","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1200\/JCO.2013.51.7219","volume":"32","author":"S Falk","year":"2014","unstructured":"Falk S, Dickenson AH (2014) Pain and nociception: mechanisms of cancer-induced bone pain. J Clin Oncol 32:1647\u20131654. https:\/\/doi.org\/10.1200\/JCO.2013.51.7219","journal-title":"J Clin Oncol"},{"key":"2464_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nrc2618","volume":"9","author":"JA Joyce","year":"2009","unstructured":"Joyce JA, Pollard JW (2009) Microenvironmental regulation of metastasis. Nat Rev Cancer 9:239\u2013252. https:\/\/doi.org\/10.1038\/nrc2618","journal-title":"Nat Rev Cancer"},{"key":"2464_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jare.2021.06.006","volume":"35","author":"XQ Zheng","year":"2022","unstructured":"Zheng XQ, Wu YH, Huang JF, Wu AM (2022) Neurophysiological mechanisms of cancer-induced bone pain. J Adv Res 35:117\u2013127. https:\/\/doi.org\/10.1016\/j.jare.2021.06.006","journal-title":"J Adv Res"},{"issue":"Suppl 1","key":"2464_CR14","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1016\/j.pain.2013.07.044","volume":"154","author":"P Mantyh","year":"2013","unstructured":"Mantyh P (2013) Bone cancer pain: causes, consequences, and therapeutic opportunities. Pain 154(Suppl 1):S54\u2013S62. https:\/\/doi.org\/10.1016\/j.pain.2013.07.044","journal-title":"Pain"},{"key":"2464_CR15","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.pain.2013.02.033","volume":"154","author":"GL Currie","year":"2013","unstructured":"Currie GL, Delaney A, Bennett MI, Dickenson AH, Egan KJ, Vesterinen HM, Sena ES, Macleod MR, Colvin LA, Fallon MT (2013) Animal models of bone cancer pain: systematic review and meta-analyses. Pain 154:917\u2013926. https:\/\/doi.org\/10.1016\/j.pain.2013.02.033","journal-title":"Pain"},{"key":"2464_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4137\/CGM.S21215","volume":"8","author":"LM Slosky","year":"2015","unstructured":"Slosky LM, Largent-Milnes TM, Vanderah TW (2015) Use of animal models in understanding cancer-induced bone pain. Cancer Growth Metastasis 8:47\u201362. https:\/\/doi.org\/10.4137\/CGM.S21215","journal-title":"Cancer Growth Metastasis"},{"key":"2464_CR17","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.bbrc.2006.04.186","volume":"345","author":"QL Mao-Ying","year":"2006","unstructured":"Mao-Ying QL, Zhao J, Dong ZQ, Wang J, Yu J, Yan MF, Zhang YQ, Wu GC, Wang YQ (2006) A rat model of bone cancer pain induced by intra-tibia inoculation of Walker 256 mammary gland carcinoma cells. Biochem Biophys Res Commun 345:1292\u20131298. https:\/\/doi.org\/10.1016\/j.bbrc.2006.04.186","journal-title":"Biochem Biophys Res Commun"},{"key":"2464_CR18","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11916-014-0423-6","volume":"18","author":"GL Currie","year":"2014","unstructured":"Currie GL, Sena ES, Fallon MT, Macleod MR, Colvin LA (2014) Using animal models to understand cancer pain in humans. Curr Pain Headache Rep 18:423. https:\/\/doi.org\/10.1007\/s11916-014-0423-6","journal-title":"Curr Pain Headache Rep"},{"key":"2464_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"2464_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.brainresbull.2019.04.009","volume":"149","author":"KX Zhou","year":"2019","unstructured":"Zhou KX, He XT, Hu XF, Zhao WJ, Li CX, Zhang C, Zhang T, Gu ZX, Deng JP, Dong YL (2019) XPro1595 ameliorates bone cancer pain in rats via inhibiting p38-mediated glial cell activation and neuroinflammation in the spinal dorsal horn. Brain Res Bull 149:137\u2013147. https:\/\/doi.org\/10.1016\/j.brainresbull.2019.04.009","journal-title":"Brain Res Bull"},{"key":"2464_CR21","doi-asserted-by":"publisher","DOI":"10.1177\/1744806919830240","author":"J Zhang","year":"2019","unstructured":"Zhang J, Wang LP, Wang HS, Su ZB, Pang XC (2019) Neuroinflammation and central PI3K\/Akt\/mTOR signal pathway contribute to bone cancer pain. Mol Pain. https:\/\/doi.org\/10.1177\/1744806919830240","journal-title":"Mol Pain"},{"key":"2464_CR22","doi-asserted-by":"publisher","first-page":"174480691985798","DOI":"10.1177\/1744806919857981","volume":"15","author":"D Zhao","year":"2019","unstructured":"Zhao D, Han DF, Wang SS, Lv B, Wang X, Ma C (2019) Roles of tumor necrosis factor-alpha and interleukin-6 in regulating bone cancer pain via TRPA1 signal pathway and beneficial effects of inhibition of neuro-inflammation and TRPA1. Mol Pain 15:1744806919857981. https:\/\/doi.org\/10.1177\/1744806919857981","journal-title":"Mol Pain"},{"key":"2464_CR23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jpain.2017.10.003","volume":"19","author":"S Liu","year":"2018","unstructured":"Liu S, Liu YP, Lv Y, Yao JL, Yue DM, Zhang MY, Qi DY, Liu GJ (2018) IL-18 contributes to bone cancer pain by regulating glia cells and neuron interaction. J Pain 19:186\u2013195. https:\/\/doi.org\/10.1016\/j.jpain.2017.10.003","journal-title":"J Pain"},{"key":"2464_CR24","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1089\/jir.2012.0146","volume":"33","author":"Y Zhao","year":"2013","unstructured":"Zhao Y, Tian L, Sheng W, Miao J, Yang J (2013) Hypalgesia effect of IL-24, a quite new mechanism for IL-24 application in cancer treatment. J Interferon Cytokine Res 33:606\u2013611. https:\/\/doi.org\/10.1089\/jir.2012.0146","journal-title":"J Interferon Cytokine Res"},{"key":"2464_CR25","doi-asserted-by":"publisher","first-page":"5222","DOI":"10.1523\/JNEUROSCI.2204-18.2019","volume":"39","author":"F Zhang","year":"2019","unstructured":"Zhang F, Wang Y, Liu Y, Han H, Zhang D, Fan X, Du X, Gamper N, Zhang H (2019) Transcriptional regulation of voltage-gated sodium channels contributes to GM-CSF-induced pain. J Neurosci 39:5222\u20135233. https:\/\/doi.org\/10.1523\/JNEUROSCI.2204-18.2019","journal-title":"J Neurosci"},{"key":"2464_CR26","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.neulet.2019.02.024","volume":"701","author":"Y Yan","year":"2019","unstructured":"Yan Y, Liang Y, Ding T, Chu H (2019) PI3K\/Akt signaling pathway may be involved in MCP-1-induced P2X4R expression in cultured microglia and cancer-induced bone pain rats. Neurosci Lett 701:100\u2013105. https:\/\/doi.org\/10.1016\/j.neulet.2019.02.024","journal-title":"Neurosci Lett"},{"key":"2464_CR27","doi-asserted-by":"publisher","first-page":"174480691878868","DOI":"10.1177\/1744806918788681","volume":"14","author":"Y Wang","year":"2018","unstructured":"Wang Y, Ni H, Li H, Deng H, Xu LS, Xu S, Zhen Y, Shen H, Pan H, Yao M (2018) Nuclear factor kappa B regulated monocyte chemoattractant protein-1\/chemokine CC motif receptor-2 expressing in spinal cord contributes to the maintenance of cancer-induced bone pain in rats. Mol Pain 14:1744806918788681. https:\/\/doi.org\/10.1177\/1744806918788681","journal-title":"Mol Pain"},{"key":"2464_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-018-1391-2","volume":"16","author":"H Ni","year":"2019","unstructured":"Ni H, Wang Y, An K, Liu Q, Xu L, Zhu C, Deng H, He Q, Wang T, Xu M et al (2019) Crosstalk between NFkappaB-dependent astrocytic CXCL1 and neuron CXCR2 plays a role in descending pain facilitation. J Neuroinflammation 16:1. https:\/\/doi.org\/10.1186\/s12974-018-1391-2","journal-title":"J Neuroinflammation"},{"key":"2464_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s11596-016-1547-1","volume":"36","author":"ZL Wang","year":"2016","unstructured":"Wang ZL, Du TT, Zhang RG (2016) JNK in spinal cord facilitates bone cancer pain in rats through modulation of CXCL1. J Huazhong Univ Sci Technolog Med Sci 36:88\u201394. https:\/\/doi.org\/10.1007\/s11596-016-1547-1","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"2464_CR30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10549-013-2807-4","volume":"143","author":"H Bu","year":"2014","unstructured":"Bu H, Shu B, Gao F, Liu C, Guan X, Ke C, Cao F, Hinton AO, Xiang H, Yang H et al (2014) Spinal IFN-\u03b3-induced protein-10 (CXCL10) mediates metastatic breast cancer-induced bone pain by activation of microglia in rat models. Breast Cancer Res Treat 143:255\u2013263. https:\/\/doi.org\/10.1007\/s10549-013-2807-4","journal-title":"Breast Cancer Res Treat"},{"key":"2464_CR31","doi-asserted-by":"publisher","first-page":"174480692091956","DOI":"10.1177\/1744806920919568","volume":"16","author":"H Xu","year":"2020","unstructured":"Xu H, Peng C, Chen XT, Yao YY, Chen LP, Yin Q, Shen W (2020) Chemokine receptor CXCR4 activates the RhoA\/ROCK2 pathway in spinal neurons that induces bone cancer pain. Mol Pain 16:1744806920919568. https:\/\/doi.org\/10.1177\/1744806920919568","journal-title":"Mol Pain"},{"key":"2464_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-11-75","author":"W Shen","year":"2014","unstructured":"Shen W, Hu XM, Liu YN, Han Y, Chen LP, Wang CC, Song C (2014) CXCL12 in astrocytes contributes to bone cancer pain through CXCR4-mediated neuronal sensitization and glial activation in rat spinal cord. J Neuroinflammation. https:\/\/doi.org\/10.1186\/1742-2094-11-75","journal-title":"J Neuroinflammation"},{"key":"2464_CR33","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1038\/s41598-017-04198-3","volume":"7","author":"XM Hu","year":"2017","unstructured":"Hu XM, Zhang H, Xu H, Zhang HL, Chen LP, Cui WQ, Yang W, Shen W (2017) Chemokine receptor CXCR4 regulates CaMKII\/CREB pathway in spinal neurons that underlies cancer-induced bone pain. Sci Rep 7:4005. https:\/\/doi.org\/10.1038\/s41598-017-04198-3","journal-title":"Sci Rep"},{"key":"2464_CR34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neuroscience.2019.02.025","volume":"406","author":"HL Bu","year":"2019","unstructured":"Bu HL, Xia YZ, Liu PM, Guo HM, Yuan C, Fan XC, Huang C, Wen YY, Kong CL, Wang T et al (2019) The roles of chemokine CXCL13 in the development of bone cancer pain and the regulation of morphine analgesia in rats. Neuroscience 406:62\u201372. https:\/\/doi.org\/10.1016\/j.neuroscience.2019.02.025","journal-title":"Neuroscience"},{"key":"2464_CR35","doi-asserted-by":"publisher","first-page":"4612","DOI":"10.12659\/msm.897702","volume":"22","author":"SF Wang","year":"2016","unstructured":"Wang SF, Dong CG, Yang X, Yin JJ (2016) Upregulation of (C-X-C motif) ligand 13 (CXCL13) attenuates morphine analgesia in rats with cancer-induced bone pain. Med Sci Monit 22:4612\u20134622. https:\/\/doi.org\/10.12659\/msm.897702","journal-title":"Med Sci Monit"},{"key":"2464_CR36","doi-asserted-by":"publisher","first-page":"174480691668890","DOI":"10.1177\/1744806916688901","volume":"13","author":"J Wei","year":"2017","unstructured":"Wei J, Li M, Wang D, Zhu H, Kong X, Wang S, Zhou YL, Ju Z, Xu GY, Jiang GQ (2017) Overexpression of suppressor of cytokine signaling 3 in dorsal root ganglion attenuates cancer-induced pain in rats. Mol Pain 13:1744806916688901. https:\/\/doi.org\/10.1177\/1744806916688901","journal-title":"Mol Pain"},{"key":"2464_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104339","volume":"147","author":"SP Chen","year":"2019","unstructured":"Chen SP, Zhou YQ, Wang XM, Sun J, Cao F, HaiSam S, Ye DW, Tian YK (2019) Pharmacological inhibition of the NLRP3 in fl ammasome as a potential target for cancer-induced bone pain. Pharmacol Res 147:104339. https:\/\/doi.org\/10.1016\/j.phrs.2019.104339","journal-title":"Pharmacol Res"},{"key":"2464_CR38","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.expneurol.2018.02.003","volume":"303","author":"K An","year":"2018","unstructured":"An K, Rong H, Ni H, Zhu C, Xu L, Liu Q, Chen Y, Zheng Y, Huang B, Yao M (2018) Spinal PKC activation - Induced neuronal HMGB1 translocation contributes to hyperalgesia in a bone cancer pain model in rats. Exp Neurol 303:80\u201394. https:\/\/doi.org\/10.1016\/j.expneurol.2018.02.003","journal-title":"Exp Neurol"},{"key":"2464_CR39","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.bbrc.2010.04.086","volume":"395","author":"W Tong","year":"2010","unstructured":"Tong W, Wang W, Huang J, Ren N, Wu SX, Li YQ (2010) Spinal high-mobility group box 1 contributes to mechanical allodynia in a rat model of bone cancer pain. Biochem Biophys Res Commun 395:572\u2013576. https:\/\/doi.org\/10.1016\/j.bbrc.2010.04.086","journal-title":"Biochem Biophys Res Commun"},{"key":"2464_CR40","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.neuroscience.2008.04.072","volume":"154","author":"RX Zhang","year":"2008","unstructured":"Zhang RX, Liu B, Li A, Wang L, Ren K, Qiao JT, Berman BM, Lao L (2008) Interleukin 1\u03b2 facilitates bone cancer pain in rats by enhancing NMDA receptor NR-1 subunit phosphorylation. Neuroscience 154:1533\u20131538. https:\/\/doi.org\/10.1016\/j.neuroscience.2008.04.072","journal-title":"Neuroscience"},{"key":"2464_CR41","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1097\/j.pain.0000000000001139","volume":"159","author":"B Remeniuk","year":"2018","unstructured":"Remeniuk B, King T, Sukhtankar D, Nippert A, Li N, Li F, Cheng K, Rice KC, Porreca F (2018) Disease modifying actions of interleukin-6 blockade in a rat model of bone cancer pain. Pain 159:684\u2013698. https:\/\/doi.org\/10.1097\/j.pain.0000000000001139","journal-title":"Pain"},{"key":"2464_CR42","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bbi.2019.01.024","volume":"79","author":"W Huo","year":"2019","unstructured":"Huo W, Liu Y, Lei Y, Zhang Y, Huang Y, Mao Y, Wang C, Sun Y, Zhang W, Ma Z et al (2019) Imbalanced spinal infiltration of Th17\/Treg cells contributes to bone cancer pain via promoting microglial activation. Brain Behav Immun 79:139\u2013151. https:\/\/doi.org\/10.1016\/j.bbi.2019.01.024","journal-title":"Brain Behav Immun"},{"key":"2464_CR43","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.neuroscience.2013.08.026","volume":"253","author":"J Zhao","year":"2013","unstructured":"Zhao J, Zhang H, Liu SB, Han P, Hu S, Li Q, Wang ZF, Mao-Ying QL, Chen HM, Jiang JW et al (2013) Spinal interleukin-33 and its receptor ST2 contribute to bone cancer-induced pain in mice. Neuroscience 253:172\u2013182. https:\/\/doi.org\/10.1016\/j.neuroscience.2013.08.026","journal-title":"Neuroscience"},{"key":"2464_CR44","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.neuroscience.2010.04.022","volume":"169","author":"C Geis","year":"2010","unstructured":"Geis C, Graulich M, Wissmann A, Hagenacker T, Thomale J, Sommer C, Sch\u00e4fers M (2010) Evoked pain behavior and spinal glia activation is dependent on tumor necrosis factor receptor 1 and 2 in a mouse model of bone cancer pain. Neuroscience 169:463\u2013474. https:\/\/doi.org\/10.1016\/j.neuroscience.2010.04.022","journal-title":"Neuroscience"},{"key":"2464_CR45","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/rapm.2000.0830110","volume":"25","author":"R Friedman","year":"2000","unstructured":"Friedman R (2000) Pain at the cellular level: the role of the cytokine tumor necrosis factor-alpha. Reg Anesth Pain Med 25:110\u2013112. https:\/\/doi.org\/10.1053\/rapm.2000.0830110","journal-title":"Reg Anesth Pain Med"},{"key":"2464_CR46","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.pharmthera.2006.04.001","volume":"112","author":"WA Verri Jr","year":"2006","unstructured":"Verri WA Jr, Cunha TM, Parada CA, Poole S, Cunha FQ, Ferreira SH (2006) Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development? Pharmacol Ther 112:116\u2013138. https:\/\/doi.org\/10.1016\/j.pharmthera.2006.04.001","journal-title":"Pharmacol Ther"},{"key":"2464_CR47","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1248\/yakushi1947.120.5_455","volume":"120","author":"S Ohishi","year":"2000","unstructured":"Ohishi S (2000) Evaluation of time course and inter-relationship of inflammatory mediators in experimental inflammatory reaction. Yakugaku Zasshi 120:455\u2013462","journal-title":"Yakugaku Zasshi"},{"key":"2464_CR48","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/j.1476-5381.1992.tb14503.x","volume":"107","author":"FQ Cunha","year":"1992","unstructured":"Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH (1992) The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol 107:660\u2013664. https:\/\/doi.org\/10.1111\/j.1476-5381.1992.tb14503.x","journal-title":"Br J Pharmacol"},{"key":"2464_CR49","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1139\/y95-113","volume":"73","author":"MN Perkins","year":"1995","unstructured":"Perkins MN, Kelly D, Davis AJ (1995) Bradykinin B1 and B2 receptor mechanisms and cytokine-induced hyperalgesia in the rat. Can J Physiol Pharmacol 73:832\u2013836. https:\/\/doi.org\/10.1139\/y95-113","journal-title":"Can J Physiol Pharmacol"},{"key":"2464_CR50","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/sj.bjp.0701148","volume":"121","author":"CJ Woolf","year":"1997","unstructured":"Woolf CJ, Allchorne A, Safieh-Garabedian B, Poole S (1997) Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br J Pharmacol 121:417\u2013424. https:\/\/doi.org\/10.1038\/sj.bjp.0701148","journal-title":"Br J Pharmacol"},{"key":"2464_CR51","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1006\/exnr.1998.6797","volume":"151","author":"C Sommer","year":"1998","unstructured":"Sommer C, Schmidt C, George A (1998) Hyperalgesia in experimental neuropathy is dependent on the TNF receptor 1. Exp Neurol 151:138\u2013142. https:\/\/doi.org\/10.1006\/exnr.1998.6797","journal-title":"Exp Neurol"},{"key":"2464_CR52","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1097\/00001756-199808240-00026","volume":"9","author":"R Wagner","year":"1998","unstructured":"Wagner R, Myers RR, O\u2019Brien JS (1998) Prosaptide prevents hyperalgesia and reduces peripheral TNFR1 expression following TNF-alpha nerve injection. NeuroReport 9:2827\u20132831. https:\/\/doi.org\/10.1097\/00001756-199808240-00026","journal-title":"NeuroReport"},{"key":"2464_CR53","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/s0006-8993(97)01327-9","volume":"784","author":"C Sommer","year":"1998","unstructured":"Sommer C, Schafers M (1998) Painful mononeuropathy in C57BL\/Wld mice with delayed wallerian degeneration: differential effects of cytokine production and nerve regeneration on thermal and mechanical hypersensitivity. Brain Res 784:154\u2013162. https:\/\/doi.org\/10.1016\/s0006-8993(97)01327-9","journal-title":"Brain Res"},{"key":"2464_CR54","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/0306-4522(96)00127-3","volume":"73","author":"R Wagner","year":"1996","unstructured":"Wagner R, Myers RR (1996) Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves. Neuroscience 73:625\u2013629. https:\/\/doi.org\/10.1016\/0306-4522(96)00127-3","journal-title":"Neuroscience"},{"key":"2464_CR55","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1523\/JNEUROSCI.23-07-02517.2003","volume":"23","author":"M Schafers","year":"2003","unstructured":"Schafers M, Svensson CI, Sommer C, Sorkin LS (2003) Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J Neurosci 23:2517\u20132521. https:\/\/doi.org\/10.1523\/JNEUROSCI.23-07-02517.2003","journal-title":"J Neurosci"},{"key":"2464_CR56","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1006\/exnr.1999.7193","volume":"160","author":"A George","year":"1999","unstructured":"George A, Schmidt C, Weishaupt A, Toyka KV, Sommer C (1999) Serial determination of tumor necrosis factor-alpha content in rat sciatic nerve after chronic constriction injury. Exp Neurol 160:124\u2013132. https:\/\/doi.org\/10.1006\/exnr.1999.7193","journal-title":"Exp Neurol"},{"key":"2464_CR57","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1046\/j.1460-9568.2003.02504.x","volume":"17","author":"M Schafers","year":"2003","unstructured":"Schafers M, Geis C, Svensson CI, Luo ZD, Sommer C (2003) Selective increase of tumour necrosis factor-alpha in injured and spared myelinated primary afferents after chronic constrictive injury of rat sciatic nerve. Eur J Neurosci 17:791\u2013804. https:\/\/doi.org\/10.1046\/j.1460-9568.2003.02504.x","journal-title":"Eur J Neurosci"},{"key":"2464_CR58","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1128\/iai.60.4.1441-1446.1992","volume":"60","author":"PF Barnes","year":"1992","unstructured":"Barnes PF, Chatterjee D, Brennan PJ, Rea TH, Modlin RL (1992) Tumor necrosis factor production in patients with leprosy. Infect Immun 60:1441\u20131446. https:\/\/doi.org\/10.1128\/iai.60.4.1441-1446.1992","journal-title":"Infect Immun"},{"key":"2464_CR59","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00401-003-0689-y","volume":"105","author":"T Lindenlaub","year":"2003","unstructured":"Lindenlaub T, Sommer C (2003) Cytokines in sural nerve biopsies from inflammatory and non-inflammatory neuropathies. Acta Neuropathol 105:593\u2013602. https:\/\/doi.org\/10.1007\/s00401-003-0689-y","journal-title":"Acta Neuropathol"},{"key":"2464_CR60","doi-asserted-by":"publisher","unstructured":"Shafer DM, Assael L, White LB, Rossomando EF (1994) Tumor necrosis factor-alpha as a biochemical marker of pain and outcome in temporomandibular joints with internal derangements. J Oral Maxillofac Surg 52:786\u2013791; discussion 791\u2013782. https:\/\/doi.org\/10.1016\/0278-2391(94)90217-8","DOI":"10.1016\/0278-2391(94)90217-8"},{"key":"2464_CR61","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/art.1780400206","volume":"40","author":"PP Tak","year":"1997","unstructured":"Tak PP, Smeets TJ, Daha MR, Kluin PM, Meijers KA, Brand R, Meinders AE, Breedveld FC (1997) Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum 40:217\u2013225. https:\/\/doi.org\/10.1002\/art.1780400206","journal-title":"Arthritis Rheum"},{"key":"2464_CR62","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc2628","volume":"9","author":"F Balkwill","year":"2009","unstructured":"Balkwill F (2009) Tumour necrosis factor and cancer. Nat Rev Cancer 9:361\u2013371. https:\/\/doi.org\/10.1038\/nrc2628","journal-title":"Nat Rev Cancer"},{"key":"2464_CR63","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.canlet.2012.10.014","volume":"328","author":"WM Chu","year":"2013","unstructured":"Chu WM (2013) Tumor necrosis factor. Cancer Lett 328:222\u2013225. https:\/\/doi.org\/10.1016\/j.canlet.2012.10.014","journal-title":"Cancer Lett"},{"key":"2464_CR64","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","volume":"45","author":"JM Zhang","year":"2007","unstructured":"Zhang JM, An J (2007) Cytokines, inflammation, and pain. Int Anesthesiol Clin 45:27\u201337. https:\/\/doi.org\/10.1097\/AIA.0b013e318034194e","journal-title":"Int Anesthesiol Clin"},{"key":"2464_CR65","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/35068566","volume":"410","author":"TA Samad","year":"2001","unstructured":"Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, Bonventre JV, Woolf CJ (2001) Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410:471\u2013475. https:\/\/doi.org\/10.1038\/35068566","journal-title":"Nature"},{"key":"2464_CR66","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1460-9568.2004.03514.x","volume":"20","author":"V Raghavendra","year":"2004","unstructured":"Raghavendra V, Tanga FY, DeLeo JA (2004) Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. Eur J Neurosci 20:467\u2013473. https:\/\/doi.org\/10.1111\/j.1460-9568.2004.03514.x","journal-title":"Eur J Neurosci"},{"key":"2464_CR67","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/cne.2000","volume":"439","author":"BA Winkelstein","year":"2001","unstructured":"Winkelstein BA, Rutkowski MD, Sweitzer SM, Pahl JL, DeLeo JA (2001) Nerve injury proximal or distal to the DRG induces similar spinal glial activation and selective cytokine expression but differential behavioral responses to pharmacologic treatment. J Comp Neurol 439:127\u2013139","journal-title":"J Comp Neurol"},{"key":"2464_CR68","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1124\/jpet.103.052407","volume":"306","author":"V Raghavendra","year":"2003","unstructured":"Raghavendra V, Tanga F, DeLeo JA (2003) Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther 306:624\u2013630. https:\/\/doi.org\/10.1124\/jpet.103.052407","journal-title":"J Pharmacol Exp Ther"},{"key":"2464_CR69","first-page":"1","volume":"521","author":"LR Watkins","year":"2003","unstructured":"Watkins LR, Milligan ED, Maier SF (2003) Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain. Adv Exp Med Biol 521:1\u201321","journal-title":"Adv Exp Med Biol"},{"key":"2464_CR70","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/s0165-5728(01)00324-1","volume":"118","author":"JC Copray","year":"2001","unstructured":"Copray JC, Mantingh I, Brouwer N, Biber K, Kust BM, Liem RS, Huitinga I, Tilders FJ, Van Dam AM, Boddeke HW (2001) Expression of interleukin-1 beta in rat dorsal root ganglia. J Neuroimmunol 118:203\u2013211. https:\/\/doi.org\/10.1016\/s0165-5728(01)00324-1","journal-title":"J Neuroimmunol"},{"key":"2464_CR71","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1053\/eujp.2000.0177","volume":"4","author":"AJ Reeve","year":"2000","unstructured":"Reeve AJ, Patel S, Fox A, Walker K, Urban L (2000) Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. Eur J Pain 4:247\u2013257. https:\/\/doi.org\/10.1053\/eujp.2000.0177","journal-title":"Eur J Pain"},{"key":"2464_CR72","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s13075-015-0858-0","volume":"17","author":"M Ebbinghaus","year":"2015","unstructured":"Ebbinghaus M, Segond von Banchet G, Massier J, Gajda M, Brauer R, Kress M, Schaible HG (2015) Interleukin-6-dependent influence of nociceptive sensory neurons on antigen-induced arthritis. Arthritis Res Ther 17:334. https:\/\/doi.org\/10.1186\/s13075-015-0858-0","journal-title":"Arthritis Res Ther"},{"key":"2464_CR73","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ejphar.2008.07.008","volume":"592","author":"N Kiguchi","year":"2008","unstructured":"Kiguchi N, Maeda T, Kobayashi Y, Kondo T, Ozaki M, Kishioka S (2008) The critical role of invading peripheral macrophage-derived interleukin-6 in vincristine-induced mechanical allodynia in mice. Eur J Pharmacol 592:87\u201392. https:\/\/doi.org\/10.1016\/j.ejphar.2008.07.008","journal-title":"Eur J Pharmacol"},{"key":"2464_CR74","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12974-016-0607-6","volume":"13","author":"YQ Zhou","year":"2016","unstructured":"Zhou YQ, Liu Z, Liu ZH, Chen SP, Li M, Shahveranov A, Ye DW, Tian YK (2016) Interleukin-6: an emerging regulator of pathological pain. J Neuroinflammation 13:141. https:\/\/doi.org\/10.1186\/s12974-016-0607-6","journal-title":"J Neuroinflammation"},{"key":"2464_CR75","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.ejca.2010.02.026","volume":"46","author":"T Ara","year":"2010","unstructured":"Ara T, Declerck YA (2010) Interleukin-6 in bone metastasis and cancer progression. Eur J Cancer 46:1223\u20131231. https:\/\/doi.org\/10.1016\/j.ejca.2010.02.026","journal-title":"Eur J Cancer"},{"key":"2464_CR76","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.immuni.2009.09.010","volume":"31","author":"RM Ransohoff","year":"2009","unstructured":"Ransohoff RM (2009) Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity 31:711\u2013721. https:\/\/doi.org\/10.1016\/j.immuni.2009.09.010","journal-title":"Immunity"},{"key":"2464_CR77","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.tips.2005.11.002","volume":"27","author":"EE Ubogu","year":"2006","unstructured":"Ubogu EE, Cossoy MB, Ransohoff RM (2006) The expression and function of chemokines involved in CNS inflammation. Trends Pharmacol Sci 27:48\u201355. https:\/\/doi.org\/10.1016\/j.tips.2005.11.002","journal-title":"Trends Pharmacol Sci"},{"key":"2464_CR78","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.it.2005.08.001","volume":"26","author":"C Abbadie","year":"2005","unstructured":"Abbadie C (2005) Chemokines, chemokine receptors and pain. Trends Immunol 26:529\u2013534. https:\/\/doi.org\/10.1016\/j.it.2005.08.001","journal-title":"Trends Immunol"},{"key":"2464_CR79","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.coph.2011.10.007","volume":"12","author":"N Kiguchi","year":"2012","unstructured":"Kiguchi N, Kobayashi Y, Kishioka S (2012) Chemokines and cytokines in neuroinflammation leading to neuropathic pain. Curr Opin Pharmacol 12:55\u201361. https:\/\/doi.org\/10.1016\/j.coph.2011.10.007","journal-title":"Curr Opin Pharmacol"},{"key":"2464_CR80","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nrd1852","volume":"4","author":"FA White","year":"2005","unstructured":"White FA, Bhangoo SK, Miller RJ (2005) Chemokines: integrators of pain and inflammation. Nat Rev Drug Discov 4:834\u2013844. https:\/\/doi.org\/10.1038\/nrd1852","journal-title":"Nat Rev Drug Discov"},{"issue":"Suppl 1","key":"2464_CR81","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.pain.2013.06.022","volume":"154","author":"RR Ji","year":"2013","unstructured":"Ji RR, Berta T, Nedergaard M (2013) Glia and pain: is chronic pain a gliopathy? Pain 154(Suppl 1):S10\u2013S28. https:\/\/doi.org\/10.1016\/j.pain.2013.06.022","journal-title":"Pain"},{"key":"2464_CR82","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s13311-020-00905-7","volume":"17","author":"CR Donnelly","year":"2020","unstructured":"Donnelly CR, Andriessen AS, Chen G, Wang K, Jiang C, Maixner W, Ji RR (2020) Central nervous system targets: glial cell mechanisms in chronic pain. Neurotherapeutics 17:846\u2013860. https:\/\/doi.org\/10.1007\/s13311-020-00905-7","journal-title":"Neurotherapeutics"},{"key":"2464_CR83","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.brainres.2018.06.011","volume":"1698","author":"X Huang","year":"2018","unstructured":"Huang X, Li J, Xie J, Li Y, Gao Y, Li X, Xu X, Shi R, Yao W, Ke C (2018) Neuronal complement cascade drives bone cancer pain via C3R mediated microglial activation. Brain Res 1698:81\u201388. https:\/\/doi.org\/10.1016\/j.brainres.2018.06.011","journal-title":"Brain Res"},{"key":"2464_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172475","volume":"858","author":"MM Ge","year":"2019","unstructured":"Ge MM, Chen SP, Zhou YQ, Li Z, Tian XB, Gao F, Manyande A, Tian YK, Yang H (2019) The therapeutic potential of GABA in neuron-glia interactions of cancer-induced bone pain. Eur J Pharmacol 858:172475. https:\/\/doi.org\/10.1016\/j.ejphar.2019.172475","journal-title":"Eur J Pharmacol"},{"key":"2464_CR85","first-page":"E1199","volume":"25","author":"P Wu","year":"2022","unstructured":"Wu P, Wu X, Zhou G, Wang Y, Liu X, Lv R, Liu Y, Wen Q (2022) P2X7 receptor-induced bone cancer pain by regulating microglial activity via NLRP3\/IL-1beta signaling. Pain Physician 25:E1199\u2013E1210","journal-title":"Pain Physician"},{"key":"2464_CR86","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s10549-011-1851-1","volume":"133","author":"C Panis","year":"2012","unstructured":"Panis C, Victorino VJ, Herrera AC, Freitas LF, De Rossi T, Campos FC, Simao AN, Barbosa DS, Pinge-Filho P, Cecchini R et al (2012) Differential oxidative status and immune characterization of the early and advanced stages of human breast cancer. Breast Cancer Res Treat 133:881\u2013888. https:\/\/doi.org\/10.1007\/s10549-011-1851-1","journal-title":"Breast Cancer Res Treat"},{"key":"2464_CR87","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1093\/pm\/pnx145","volume":"19","author":"S Al-Mazidi","year":"2018","unstructured":"Al-Mazidi S, Farhat K, Nedjadi T, Chaudhary A, Al-Abdin OZ, Rabah D, Al-Zoghaibi M, Djouhri L (2018) Association of interleukin-6 and other cytokines with self-reported pain in prostate cancer patients receiving chemotherapy. Pain Med 19:1058\u20131066. https:\/\/doi.org\/10.1093\/pm\/pnx145","journal-title":"Pain Med"},{"key":"2464_CR88","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2147\/JPR.S227175","volume":"13","author":"J Fazzari","year":"2020","unstructured":"Fazzari J, Sidhu J, Motkur S, Inman M, Buckley N, Clemons M, Vandermeer L, Singh G (2020) Applying serum cytokine levels to predict pain severity in cancer patients. J Pain Res 13:313\u2013321. https:\/\/doi.org\/10.2147\/JPR.S227175","journal-title":"J Pain Res"},{"key":"2464_CR89","doi-asserted-by":"publisher","first-page":"551","DOI":"10.7326\/0003-4819-156-8-201204170-00397","volume":"156","author":"SP Cohen","year":"2012","unstructured":"Cohen SP, White RL, Kurihara C, Larkin TM, Chang A, Griffith SR, Gilligan C, Larkin R, Morlando B, Pasquina PF et al (2012) Epidural steroids, etanercept, or saline in subacute sciatica: a multicenter, randomized trial. Ann Intern Med 156:551\u2013559. https:\/\/doi.org\/10.7326\/0003-4819-156-8-201204170-00397","journal-title":"Ann Intern Med"},{"key":"2464_CR90","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00586-012-2183-5","volume":"21","author":"S Ohtori","year":"2012","unstructured":"Ohtori S, Miyagi M, Eguchi Y, Inoue G, Orita S, Ochiai N, Kishida S, Kuniyoshi K, Nakamura J, Aoki Y et al (2012) Efficacy of epidural administration of anti-interleukin-6 receptor antibody onto spinal nerve for treatment of sciatica. Eur Spine J 21:2079\u20132084. https:\/\/doi.org\/10.1007\/s00586-012-2183-5","journal-title":"Eur Spine J"},{"key":"2464_CR91","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/01.anes.0000267518.20363.0d","volume":"107","author":"SP Cohen","year":"2007","unstructured":"Cohen SP, Wenzell D, Hurley RW, Kurihara C, Buckenmaier CC 3rd, Griffith S, Larkin TM, Dahl E, Morlando BJ (2007) A double-blind, placebo-controlled, dose-response pilot study evaluating intradiscal etanercept in patients with chronic discogenic low back pain or lumbosacral radiculopathy. Anesthesiology 107:99\u2013105. https:\/\/doi.org\/10.1097\/01.anes.0000267518.20363.0d","journal-title":"Anesthesiology"},{"key":"2464_CR92","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1213\/ANE.0b013e318273f71c","volume":"116","author":"SP Cohen","year":"2013","unstructured":"Cohen SP, Galvagno SM, Plunkett A, Harris D, Kurihara C, Turabi A, Rehrig S, Buckenmaier CC 3rd, Chelly JE (2013) A multicenter, randomized, controlled study evaluating preventive etanercept on postoperative pain after inguinal hernia repair. Anesth Analg 116:455\u2013462. https:\/\/doi.org\/10.1213\/ANE.0b013e318273f71c","journal-title":"Anesth Analg"},{"key":"2464_CR93","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jos.2015.10.005","volume":"21","author":"T Sainoh","year":"2016","unstructured":"Sainoh T, Orita S, Miyagi M, Inoue G, Yamauchi K, Suzuki M, Sakuma Y, Kubota G, Oikawa Y, Inage K et al (2016) Single intradiscal injection of the interleukin-6 receptor antibody tocilizumab provides short-term relief of discogenic low back pain; prospective comparative cohort study. J Orthop Sci 21:2\u20136. https:\/\/doi.org\/10.1016\/j.jos.2015.10.005","journal-title":"J Orthop Sci"},{"key":"2464_CR94","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/s0149-2918(03)80219-9","volume":"25","author":"EL Tobinick","year":"2003","unstructured":"Tobinick EL (2003) Targeted etanercept for treatment-refractory pain due to bone metastasis: two case reports. Clin Ther 25:2279\u20132288. https:\/\/doi.org\/10.1016\/s0149-2918(03)80219-9","journal-title":"Clin Ther"},{"key":"2464_CR95","doi-asserted-by":"publisher","first-page":"9259646","DOI":"10.1155\/2016\/9259646","volume":"2016","author":"P Rider","year":"2016","unstructured":"Rider P, Carmi Y, Cohen I (2016) Biologics for targeting inflammatory cytokines, clinical uses, and limitations. Int J Cell Biol 2016:9259646. https:\/\/doi.org\/10.1155\/2016\/9259646","journal-title":"Int J Cell Biol"},{"key":"2464_CR96","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1476-5381.2009.00206.x","volume":"157","author":"Z Zidek","year":"2009","unstructured":"Zidek Z, Anzenbacher P, Kmonickova E (2009) Current status and challenges of cytokine pharmacology. Br J Pharmacol 157:342\u2013361. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00206.x","journal-title":"Br J Pharmacol"},{"key":"2464_CR97","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cbpa.2021.01.007","volume":"62","author":"L Bonati","year":"2021","unstructured":"Bonati L, Tang L (2021) Cytokine engineering for targeted cancer immunotherapy. Curr Opin Chem Biol 62:43\u201352. https:\/\/doi.org\/10.1016\/j.cbpa.2021.01.007","journal-title":"Curr Opin Chem Biol"},{"key":"2464_CR98","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.595722","volume":"12","author":"JF Rossi","year":"2021","unstructured":"Rossi JF, Lu ZY, Massart C, Levon K (2021) Dynamic immune\/inflammation precision medicine: the good and the bad inflammation in infection and cancer. Front Immunol 12:595722. https:\/\/doi.org\/10.3389\/fimmu.2021.595722","journal-title":"Front Immunol"},{"key":"2464_CR99","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.pain.2010.10.035","volume":"152","author":"BJA Laird","year":"2011","unstructured":"Laird BJA, Scott AC, Colvin LA, McKeon AL, Murray GD, Fearon KCH, Fallon MT (2011) Cancer pain and its relationship to systemic inflammation: an exploratory study. Pain 152:460\u2013463. https:\/\/doi.org\/10.1016\/j.pain.2010.10.035","journal-title":"Pain"},{"key":"2464_CR100","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-1-61779-527-5_2","volume":"844","author":"EL Chiswick","year":"2012","unstructured":"Chiswick EL, Duffy E, Japp B, Remick D (2012) Detection and quantification of cytokines and other biomarkers. Methods Mol Biol 844:15\u201330. https:\/\/doi.org\/10.1007\/978-1-61779-527-5_2","journal-title":"Methods Mol Biol"},{"key":"2464_CR101","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2174\/1381612826666201102103520","volume":"27","author":"F Calapai","year":"2021","unstructured":"Calapai F, Mondello E, Mannucci C, Sorbara EE, Gangemi S, Quattrone D, Calapai G, Cardia L (2021) Pain biomarkers in cancer: an overview. Curr Pharm Des 27:293\u2013304. https:\/\/doi.org\/10.2174\/1381612826666201102103520","journal-title":"Curr Pharm Des"},{"key":"2464_CR102","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.3389\/fimmu.2019.03009","volume":"10","author":"AG Vanderwall","year":"2019","unstructured":"Vanderwall AG, Milligan ED (2019) Cytokines in pain: harnessing endogenous anti-inflammatory signaling for improved pain management. Front Immunol 10:3009. https:\/\/doi.org\/10.3389\/fimmu.2019.03009","journal-title":"Front Immunol"},{"key":"2464_CR103","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.3389\/fimmu.2019.03061","volume":"10","author":"G Goncalves Dos Santos","year":"2019","unstructured":"Goncalves Dos Santos G, Delay L, Yaksh TL, Corr M (2019) Neuraxial cytokines in pain states. Front Immunol 10:3061. https:\/\/doi.org\/10.3389\/fimmu.2019.03061","journal-title":"Front Immunol"},{"key":"2464_CR104","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s40122-024-00603-8","volume":"13","author":"AD Kaye","year":"2024","unstructured":"Kaye AD, Perilloux DM, Hawkins AM, Wester GC, Ragaland AR, Hebert SV, Kim J, Heisler M, Kelkar RA, Chami AA et al (2024) Tumor necrosis factor and interleukin modulators for pathologic pain states: a narrative review. Pain Ther 13:481\u2013493. https:\/\/doi.org\/10.1007\/s40122-024-00603-8","journal-title":"Pain Ther"},{"key":"2464_CR105","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12891-024-07289-1","volume":"25","author":"LM Puerto Valencia","year":"2024","unstructured":"Puerto Valencia LM, He Y, Wippert PM (2024) The changes of blood-based inflammatory biomarkers after non-pharmacologic interventions for chronic low back pain: a systematic review. BMC Musculoskelet Disord 25:209. https:\/\/doi.org\/10.1186\/s12891-024-07289-1","journal-title":"BMC Musculoskelet Disord"},{"key":"2464_CR106","doi-asserted-by":"publisher","first-page":"142","DOI":"10.2174\/1570159X15666171109161140","volume":"17","author":"YQ Zhou","year":"2019","unstructured":"Zhou YQ, Liu DQ, Chen SP, Sun J, Zhou XR, Xing C, Ye DW, Tian YK (2019) The role of CXCR3 in neurological diseases. Curr Neuropharmacol 17:142\u2013150. https:\/\/doi.org\/10.2174\/1570159X15666171109161140","journal-title":"Curr Neuropharmacol"},{"key":"2464_CR107","doi-asserted-by":"publisher","first-page":"204","DOI":"10.2174\/1570159X21666230811142713","volume":"22","author":"SJ Gao","year":"2024","unstructured":"Gao SJ, Liu L, Li DY, Liu DQ, Zhang LQ, Wu JY, Song FH, Zhou YQ, Mei W (2024) Interleukin-17: a putative novel pharmacological target for pathological pain. Curr Neuropharmacol 22:204\u2013216. https:\/\/doi.org\/10.2174\/1570159X21666230811142713","journal-title":"Curr Neuropharmacol"},{"key":"2464_CR108","doi-asserted-by":"publisher","first-page":"366","DOI":"10.2174\/1570159X15666171128144441","volume":"17","author":"DQ Liu","year":"2019","unstructured":"Liu DQ, Zhou YQ, Gao F (2019) Targeting cytokines for morphine tolerance: a narrative review. Curr Neuropharmacol 17:366\u2013376. https:\/\/doi.org\/10.2174\/1570159X15666171128144441","journal-title":"Curr Neuropharmacol"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-024-02464-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-024-02464-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-024-02464-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T03:43:12Z","timestamp":1724902992000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-024-02464-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":108,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["2464"],"URL":"https:\/\/doi.org\/10.1007\/s00109-024-02464-2","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,28]]},"assertion":[{"value":"14 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}